I think they are saying that the market is not factoring in the huge potential of securing this Brazilian deal with the stock currently at 2c.
No value is attributed to them potentially becoming cashflow positive and having free cash of almost $2M within a month, nor the fact that a major US distributor requested and tested product with favorable results.
IMO there way of saying wake up market - should be closer to 3 - 4c.
Then also the cashflow comment, which naturally would occur as a result of brazil.
So I think both undervalued and expect to potential receive cashflows before requiring additional capital.
I thought quarterly read great. Much rather 30 or 40 hospitals in the disribution agreement than the initial 14
ALT Price at posting:
2.1¢ Sentiment: Buy Disclosure: Held